N-tert-butyl-alpha-phenylnitrone protects against 3,4- methylenedioxymethamphetamine-induced depletion of serotonin in rats

Synapse

Volumn 31, Issue 3, 1999, Pages 169-177

  Yeh, S Y ^a,b  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b NIDA Addiction Research Center   (United States)

Author keywords

3,4 methylenedioxyamphetamine; 3,4 ethylenedioxymethamphetamine; Ethanol; Hydroxyl radicals; MDMA; N tert butyl phenylnitrone; Neurotoxicity; PBN; Superoxide radicals

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 5 HYDROXYINDOLEACETIC ACID; ALCOHOL; BRAIN MONOAMINE; FREE RADICAL; N TERT BUTYL ALPHA PHENYLNITRONE; SCAVENGER; SEROTONIN; SEROTONIN TRANSPORTER;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY TEMPERATURE; BRAIN LEVEL; BRAIN PROTECTION; CONTROLLED STUDY; MALE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM;

ANIMALS; BODY TEMPERATURE REGULATION; BRAIN; BRAIN STEM; FREE RADICALS; FRONTAL LOBE; HIPPOCAMPUS; HYDROXYINDOLEACETIC ACID; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEURONS; NITROGEN OXIDES; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN AGENTS; SPIN LABELS;

EID: 0033103959     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(19990301)31:3<169::AID-SYN1>3.0.CO;2-N     Document Type: Article

References (40)

1. 3H]paroxetinelabeled serotonin uptake sites. J Pharmacol Exp Ther 242:911-916.
2. Battaglia G, Yeh SY, De Souza EB. 1988. MDMA-induced neurotoxicity: Parameters of degeneration and recovery of brain serotonin neurons. Pharmacol Biochem Behav 29:269-274.
3. Bowyer JF, Davies DL, Schmued L, Broening HW, Newport GD, Slikker W Jr, Holson RR. 1994. Further studies of the role of hyperthermia in methamphetamine neurotoxicity. J Pharmacol Exp Ther 268:1571-1589.
4. Broening HW, Bowyer JF, Slikker W Jr. 1994. Age-dependent sensitivity of rats to long-term effects of the serotonergic neurotoxicant (+/-)-3,4-methylenedioxymethylamphetamine (MDMA) correlates with the magnitude of the MDMA-induced thermal response. J Pharmacol Exp Ther 275:325-333.
5. Cadet JL, Ladenheim B, Baum I, Calson E, Epstein C. 1994. CuZn-superoxide dismutase (CuZnSOD) transgenic mice show resistance to the lethal effects of methylenedioxyamphetamine (MDA) and of methylenedioxymethamphetamine (MDMA). Brain Res 655:259-262.
6. Cadet JL, Ladenheim B, Hirata H, Rothman R, Ali S, Calson E, Epstein C, Moran TH. 1995. Superoxide radical mediate the biochemical effects of methylenedioxymethamphetamine (MDMA): Evidence from using CuZn-superoxide dismutase transgenic mice. Synapse 21:169-176.
7. Che S, Johnson M, Hanson GR, Gibb JW. 1995. Body temperature effect on methylenedioxymethamphetamine-induced acute decrease in tryptophan hydroxylase activity. Eur J Pharmacol 293:447-453.
8. Cheny HY, Liu T, Fererstein G, Barone FC. 1993. Distribution of spin trapping compounds in rat blood and brain: In vivo microdialysis determination. Free Radic Biol Med 14:243-250.
9. Cohen G. 1994. Enzymatic/nonenzymatic sources of oxyradicals and regulation of antioxidant defenses. Ann NY Acad Sci 738:8-14.
10. Cohen GM, d'Arcy Doherty M. 1987. Free radical mediated cell toxicity by redox cycling chemicals. Br J Cancer Suppl 8:46-52.
11. Colado MI, Green AR. 1995. The spin trap reagent α-phenyl-N-tert-butyl nitrone prevents "Ecstasy"-induced neurodegeneration of 5-hydroxytrvptamine neurones. Eur J Pharmacol 280:343-346.
12. Colado MI, Murray TK, Green AR. 1993. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine. Br J Pharmacol 108:583-589.
13. Colado MI, Willaim JL, Green AR. 1995. The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4-methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype. Br J Pharmacol 115:1281-1290.
14. Colado MI, O'Shea E, Granados R, Murray TK, Green AR. 1997. In vivo evidence for free radical involvement in the degeneration of rat brain 5-HT following administration of MDMA ("Ecstasy") and p-chloroamphetamine but not the degeneration follwing fenfluramine. Br J Pharmacol 121:889-900.
15. Commins DL, Vosmer G, Virus RM, Woolverton WL, Schuster ER, Seiden LS. 1987. Biochemical and histological evidence that methylenedioxymethamphetamine (MDMA) is toxic to neurons in the rat brain. J Pharmacol Exp Ther 241:338-345.
16. Dixon WJ, Brown MB, Engelman L, Jennrich RL. 1990. BMDP statistical software manual. Berkeley: University of California Press.
17. Epstein CJ, Avraham KB, Lovett M, Smith S, Elroy-Stein O, Rotman G, Bry C, Groner Y. 1987. Transgenic mice with increased Cu/Zn-superoxide dismutase activity: Animal model of dosage effects in Down syndrome. Proc Natl Acad Sci USA 84:8044-8048.
18. Farfel GM, Seiden LS. 1995. Role of hypothermia in the mechanism of protection against serotonergic toxicity. I. Experiments using 3,4-methylenedioxymethamphetamine, dizocilpine, CGS 19755 and NBQX. J Pharmacol Exp Ther 272:860-867.
19. 3H]-DOPA in various regions of the brain. J Neurochem 13:655-659.
20. Henry JA, Jeffrey KJ, Dawling S. 1992. Toxicity and deaths from 3,4-methylenedioxy-methamphetamine ("Ecstasy"). Lancet 340:384-387.
21. Hewitt KE, Green AR. 1994. Chlormethiazole, dizocilpine and haloperidol prevent the degeneration of serotonergic nerve terminals induced by administration of MDMA ('Ecstasy') to rats. Neuropharmacology 33:1589-1595.
22. Holtzman JL, Carr ML. 1972. The temperature dependence of the components of the hepatic microsomal mixed-function oxidases. Arch Biochem Biophys 150:227-234.
23. Insel TR, Battaglia G, Johannessen JN, Marra S, De Souza EB. 1989. 3,4-methylenenedioxymethamphetamine ("Ecstasy") selectively destroys brain serotonin terminals in rhesus monkeys. J Pharmacol Exp Ther 249:713-720.
24. Kadiiska MB, Hanna PM, Jordan SJ, Mason RP. 1993. Electron spin resonance evidence for free radical generation in copper-treated vitamin E- and selenium-deficient rats: In vivo spin-trapping investigation. Mol Pharmacol 44:222-227.
25. 14-atropine metabolites in the intact and nephrectomized rat. J Pharmacol Exp Ther 147:252-259.
26. 14-atropine uptake, metabolism and excretion by the isolated perfused rat liver. J Pharmacol Exp Ther 147:260-269.
27. Kleven MS, Woolverton WL, Seiden LS. 1989. Evidence that both intragastic and subcutaneous administration of methylenendioxymethamphetamine (MDMA) produce serotonin neurotoxicity in rhesus monkeys. Brain Res 488:121-125.
28. Kil YH, Zhang J, Piantadosi CA. 1996. Brain temperature alters hydroxyl radical production during cerebral ischemia/reperfusion in rats. J Cereb Blood Metab 16:100-106.
29. Lowry OH, Roserbrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
30. Malberg JE, Sabot KE, Seiden LS. 1996. Coadministration of MDMA with drugs that protect against MDMA neurotoxicity produces different effects on body temperature in the rat. J Pharmacol Exp Ther 278:258-267.
31. Miller DB, O'Callaghan JP. 1994. Environment-, drug- and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J mouse. J Pharmacol Exp Ther 270:752-760.
32. Nash KF Jr, Meltzer HY, Gudelsky GA. 1988. Elevation of serum prolactin and cortisone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine. J Pharmacol Exp Ther 245:873-879.
33. O'Hearn E, Battaglia G, De Souza EB, Kuhar MJ, Molliver ME. 1988. Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminal in forebrain: Immunocytochemical evidence for neurotoxicity. J Neurosci 8:2788-2803.
34. Ricaurte GA, Martello AL, Katz JL, Martello MB. 1992. Lasting effects of d,l-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: Neurochemical observations. J Pharmacol Exp Ther 261:616-622.
35. Schmidt CJ. 1987. Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. J Pharmacol Exp Ther 240:1-7.
36. 2 receptors. Brain Res 529:85-90.
37. Stone DM, Stahl DC, Hanson GR, Gibb JW. 1986. The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain. Eur J Pharmacol 128:41-48.
38. Stone DM, Merchant KM, Hanson GR, Gibb JW. 1987. Immediate and long time effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin pathways in brain of rats. Neuropharmacology 26:1677-1683.
39. Tanigawa T, Kotake Y, Reinke LA. 1993. Spin trapping of superoxide radicals following stimulation of neutrophils with fMLP is temperature dependent. Free Radic Biol Med 15:425-433.
40. Yeh SY. 1997. The effect of salicylate on 3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity in rats. Pharmacol Biochem Behav 58:701-708.